In a large, population-based BC study, Fredholm et al. demonstrated increased tumour cell proliferation by Ki-67 in the young, and prognostic value for proliferation markers in subsets of the young [47], also proposing an age-dependent Ki-67 cut-off in BC. This evidence concerns the gene MKI67 and breast cancer.